Unknown

Dataset Information

0

Vitamin D status in Mainland of China: A systematic review and meta-analysis.


ABSTRACT:

Background

Low vitamin D (VitD) status is becoming a global health issue. Previous heterogenous results are urging a meta-analysis to delineate a panorama of VitD conditions in the general population in Mainland of China.

Methods

We performed a systematic review and meta-analysis by searching PubMed, Web of Science, EMBASE, China National Knowledge Infrastructure, WanFang, and VIP databases up to June 4, 2021. The inclusion criteria were as follows: (1) original articles or dissertations focused on VitD status of people in Mainland of China; and (2) studies were population-based, cross-sectional, or longitudinal cohort with baseline data. The outcomes were serum 25(OH)D concentration and the prevalence of low VitD status. Low VitD status included VitD deficiency (< 30 nmol/L) and VitD inadequacy (< 50 nmol/L). Data were estimated by Hierarchical Bayesian methods. All included studies were cross-sectional or longitudinal cohort studies about VitD status of people in Mainland of China. (Registration: PROSPERO CRD42021226130).

Findings

A total of 105 eligible studies including 234,519 subjects were included. In adults, the overall mean 25(OH)D concentration was 44.3 nmol/L (95% Credible Interval [CrI]: 39.8-48.7). The pooled prevalence of VitD deficiency and inadequacy was 20.7% (95% CrI: 11.9-32.9) and 63.2% (95% CrI: 53.5-72.3), respectively. In children and adolescents, the overall mean 25(OH)D concentration was 52.2 nmol/L (95% CrI: 46.7-57.5). The pooled prevalence of VitD deficiency and inadequacy was 23.0% (95% CrI: 8.9-44.3) and 46.8% (95% CrI: 37.2-56.6), respectively. Specially, we identified that the prevalence of VitD inadequacy increased with age in populations with age ≤ 18 years and ≥ 60 years.

Interpretation

Low VitD status is prominent in general population of Mainland of China, especially for adults.

Funding

National Major Scientific and Technological Special Project for "Significant New Drugs Development" (2017ZX09304022).

SUBMITTER: Liu W 

PROVIDER: S-EPMC8283334 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3643868 | biostudies-other
| S-EPMC5719656 | biostudies-literature
| S-EPMC3108589 | biostudies-literature
| S-EPMC5598996 | biostudies-literature
| S-EPMC6854678 | biostudies-literature
| S-EPMC7859194 | biostudies-literature
| S-EPMC3527545 | biostudies-literature
| S-EPMC6319492 | biostudies-literature
| S-EPMC6304690 | biostudies-literature